Startups
03:14
15:01
11:31
The three major A-share indices rose collectively in the morning. As of midday, the Shanghai Composite Index rose 0.15%, the Shenzhen Component Index rose 0.87%, the ChiNext Index rose 1.07%, and the Beijing Stock Exchange 50 Index rose 1.11%. The market's half-day turnover was 733.1 billion yuan, down 46.9 billion yuan from the previous day. More than 3,800 stocks rose in the market. In terms of sector themes, real estate, AI hardware, electricity, tourism and hotels, and film and television theaters led the gains; innovative drugs, education, cross-border payments, and dairy sectors led the declines. On the market, the real estate sector rose in the morning, with Nan Guo Real Estate, Savills, Chongqing Development, and Dalong Real Estate hitting the daily limit. The power sector continued to be active, with Jiuzhou Group, Huayin Electric Power, Changyuan Electric Power, Xichang Electric Power, and Huadian Liaoneng closing the board. AI hardware directions such as optical modules and copper cable high-speed connections also performed strongly, with Shijia Photonics and Zhishang Technology rising by more than 10%, and Taichen Optics, Xinyi Sheng, and Zhongji Xuchuan leading the gains. Innovative drug stocks saw partial adjustments in early trading, with Jiangsu Wuzhong hitting the daily limit, Yuandong Biopharma and Warner Pharmaceuticals falling more than 10%. The cross-border payment sector also lagged behind, with Qingdao Kingking, Xinchen Technology, and Feitian Chengxin collectively adjusting.
09:38
19:12
15:02
11:31
The three major A-share indices fell collectively in the morning trading. As of midday, the Shanghai Composite Index fell 0.1%, the Shenzhen Component Index fell 0.66%, the ChiNext Index fell 0.68%, and the Beijing Stock Exchange 50 Index fell 2.8%. The market's half-day turnover was 780.1 billion yuan, down 9.1 billion yuan from the previous day. More than 4,100 stocks fell in the market. In terms of sector themes, PEEK materials, beauty care, pet economy, electricity, banking, and chemical pharmaceutical sectors led the gains; new stocks, AI applications, computing power, and data element sectors led the declines. On the market, the power sector rose in the morning, with Huayin Power, Xichang Power, Chendian International, and Shaoneng shares hitting the daily limit. Pet economy concept stocks rose during the session, with China Pet Foods and Guaibao Pets hitting record highs, and Tianyuan Pets, Luss Pets, and Yuanfei Pets all rising sharply. Innovative drugs and chemical pharmaceutical sectors also performed actively in the morning, with Jinkai Biosciences, Hehua Co., Ltd., Kailaiying, and Lingkang Pharmaceuticals hitting the daily limit. Newly listed stocks performed poorly in the early trading session, with Gangdi Technology falling more than 10%, Jialiqi, Tianhe Magnetic Materials, and Honggong Technology all falling. AI application and computing power concept stocks also lagged behind, with Xingguang shares hitting the limit, and Xinkaipu, Xin Guodu, and Xinzhi Software leading the decline.
21:30
07:36
12:31
15:40
11:31
15:02
11:31
The three major A-share indices fell collectively in the morning trading today. As of noon, the Shanghai Composite Index fell 6.34%, the Shenzhen Component Index fell 8.01%, the ChiNext Index fell 9.74%, and the Beijing Stock Exchange 50 Index fell 10.04%. The market's half-day turnover was 1,089.2 billion yuan, an increase of 342.9 billion yuan from the previous day. More than 5,211 stocks fell in the market, and more than 1,400 stocks in the two markets hit the limit. In terms of sector themes, the agriculture and breeding sectors rose against the trend; the consumer electronics and copper cable high-speed connection sectors fell sharply. On the market, all kinds of mainstream A-share indexes fell collectively, with the Shanghai Composite 50 Index falling more than 5%, the CSI 300 Index falling more than 6%, the CSI 1000 Index falling nearly 9%, the micro-cap index falling more than 9%, and the CSI 2000 Index falling more than 10%; the agriculture, GMO, and breeding sectors rose against the market trend, with Shennong Seed, Dunhuang Seed, Beidahuang, Wanxiang Denong, Fucheng Shares, Xiangjia Shares, Jinhe Bio and many other stocks hitting the daily limit, and Xiaoming Shares and Kangnong Seed were among the top gainers; the consumer electronics sector continued to fall, with more than 20 stocks such as Goertek, Luxshare Precision, Fu Ri Electronics, Lianchuang Optoelectronics, Edifier, and Foxconn Industrial Internet hitting the daily limit. As for hot stocks, Kaimet Gas staged a ground-to-sky board in the early trading, recording 6 boards in 7 days.
20:47
Guotai Junan Securities Research Report believes that with the empowerment of AI, the shortened R&D cycle, reduced costs, and improved efficiency will all boost the IRR level of innovative pharmaceutical companies from a medium-term perspective, and the sector may be expected to usher in a new growth logic. The recovery of investment and financing activities in the global pharmaceutical industry is conducive to the improvement of financing cash flow of innovative pharmaceutical companies. In the significant upward stage of the industry's investment and financing cycle, the innovative drug sector tends to perform better in the capital market. For example, referring to the previous round from 2019 to 2021. At the same time, the central axis of US Treasury bond interest rates is likely to move downward in 2025, which may further benefit the continuation of the recovery trend in financing activities of innovative pharmaceutical companies and boost the sector's valuation. Waiting for fiscal support, there is room for innovative drug companies to repair their gross profit margins. On the one hand, the imminent release of industry policies represented by the "Class C Catalogue" may be an important catalyst for the recovery of sector valuations and sentiment. On the other hand, "social security injection" may be one of the options for fiscal support, thereby alleviating the pressure on medical insurance payments and driving the continued recovery in the growth rate of basic medical insurance expenditures. The revenue growth rate of the innovative drug sector is expected to usher in an upward inflection point, and the gross profit margin is also expected to be repaired. The "valuation expansion elasticity and space" of innovative drugs listed on the Hong Kong stock market may be stronger than that of A-shares.
Load More
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
ASIA TECH WIRE

Grasp technology trends

Download